$ALRZ Chardan Reiterates Buy on Aralez Pharmaceuticals Inc (ARLZ) Following FDA Approval
In a research report released Friday, Chardan Capital analyst Keay Nakae reiterated a Buy rating on shares of Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) with a price target of $10